Artificial Organs Market: Information by Organ Type (Artificial Kidneys, Artificial Liver, Artificial Pancreas, Artificial Heart, and Artificial Lungs), and Region — Forecast till 2029

Mar 26, 2020   The Gap between Organ Failures and  Organ Transplants In 2018, 36,528 transplants were performed in the U.S., as per the Health Resources and Services Administration. The figure seems high until we look at the number of people yet awaiting a transplant; as of July 2019, 113,000 people awaited their turn for a transplant in the U.S. About 20 people lose their lives every day waiting for a transplant — lives that could be potentially saved by bridging the gap between the number of org...
Request Free Sample Report

Table Of Content

TABLE OF CONTENTS

1          Introduction

1.1       Market Definition

1.2       Market Scope

2          Research Methodology

2.1       Primary Research

2.2       Research Methodology

2.3       Assumptions & Exclusions

2.4       Secondary Data Sources

3          Market Overview

3.1       Report Segmentation & Scope

3.2       Value Chain Analysis: Global Artificial Organs Market

3.3       Key Market Trends

3.3.1   Drivers

3.3.2   Restraints

3.3.3   Opportunities

3.4       Porter’s Five Forces Analysis

3.4.1   Bargaining Power of Suppliers

3.4.2   Bargaining Power of Buyers

3.4.3   Threat of Substitution

3.4.4   Threat of New Entrants

3.4.5   Competitive Rivalry

3.5       Market Share Analysis

3.6       Top Investment Pocket

3.7       Top winning strategies

4          Organ Type Overview

4.1       Introduction

4.1.1   Market Size & Forecast (Value)

4.2       Artificial Kidneys

4.2.1   Market Size & Forecast (Value)

4.3       Artificial Pancreas

4.3.1   Market Size & Forecast (Value)

4.4       Artificial Heart

4.4.1   Market Size & Forecast (Value)

5          Technology Overview

5.1       Introduction

5.1.1   Market Size & Forecast (Value)

5.2       Tissue Engineering

5.2.1   Market Size & Forecast (Value)

5.3       Electronic

5.3.1   Market Size & Forecast (Value)

5.4       Biochemical

5.4.1   Market Size & Forecast (Value)

6          Method of transplantation Overview

6.1       Introduction

6.1.1   Market Size & Forecast (Value)

6.2       Implantation

6.2.1   Market Size & Forecast (Value)

6.3       Wearable

6.3.1   Market Size & Forecast (Value)

6.4       Others

6.4.1   Market Size & Forecast (Value)

7          Regional Overview

7.1      Introduction

7.1.1   Market Size & Forecast (Value)

7.2      America

7.2.1   North America

7.2.1.1      U.S.

7.2.1.1.1         By Organ Type

7.2.1.1.2         By Technology

7.2.1.2 Canada

7.2.1.2.1         By Organ Type

7.2.1.2.2         By Technology

7.2.1.3 Mexico

7.2.1.3.1         By Organ Type

7.2.1.3.2         By Technology

7.2.2   Central, South America, and Caribbean

7.2.2.1      By Organ Type

7.2.2.2      By Technology

7.2.2.2.1   Brazil

7.2.2.2.1.1      By Organ Type

7.2.2.2.1.2      By Technology

7.2.2.2.2   Argentina

7.2.2.2.2.1      By Organ Type

7.2.2.2.2.2      By Technology

7.2.2.2.3   Rest of South America

7.2.2.2.3.1      By Organ Type

7.2.2.2.3.2      By Technology

7.3      Europe

7.3.1   Market Size & Forecast (Value)

7.3.2   Western Europe

7.3.2.1 U.K

7.3.2.1.1         By Organ Type

7.3.2.1.2         By Technology

7.3.2.2 Germany

7.3.2.2.1         By Organ Type

7.3.2.2.2         By Technology

7.3.2.3 France

7.3.2.3.1         By Organ Type

7.3.2.3.2         By Technology

7.3.2.4 Spain

7.3.2.4.1         By Organ Type

7.3.2.4.2         By Technology

7.3.2.5 Italy

7.3.2.5.1         By Organ Type

7.3.2.5.2         By Technology

7.3.2.6 Rest of Western Europe

7.3.2.6.1         By Organ Type

7.3.2.6.2         By Technology

7.3.3   Eastern Europe

7.3.3.1             By Organ Type

7.3.3.2             By Technology

7.3.4   Rest of Europe

7.3.4.1             By Organ Type

7.3.4.2             By Technology

7.4      Asia Pacific

7.4.1   Market Size & Forecast (Value)

7.4.2   Japan

7.4.2.1            By Organ Type

7.4.2.2            By Technology

7.4.3   China

7.4.3.1            By Organ Type

7.4.3.2            By Technology

7.4.4   Australia

7.4.4.1            By Organ Type

7.4.4.2            By Technology

7.4.5   India

7.4.5.1            By Organ Type

7.4.5.2            By Technology

7.4.6   South Korea

7.4.6.1            By Organ Type

7.4.6.2            By Technology

7.4.7   Rest of Asia-Pacific

7.4.7.1            By Organ Type

7.4.7.2            By Technology

7.5      Middle East & Africa

7.5.1   The Middle East

7.5.1.1            Market Size & Forecast (Value)

7.5.1.2            Saudi Arabia

7.5.1.2.1         By Organ Type

7.5.1.2.2         By Technology

7.5.1.3 UAE

7.5.1.3.1         By Organ Type

7.5.1.3.2         By Technology

7.5.1.4 Qatar

7.5.1.4.1         By Organ Type

7.5.1.4.2         By Technology

7.5.2   The Africa

7.5.2.1            Market Size & Forecast (Value)

8          Company Profile

8.1      Biomet Inc.

8.1.1   Company Overview

8.1.2   Financial Performance

8.1.3   Recent Developments

8.1.4   Organ Type Portfolio

8.2      Berlin heart GmbH

8.2.1   Company Overview

8.2.2   Financial Performance

8.2.3   Recent Developments

8.2.4   Organ Type Portfolio

8.3      Asahi kasei medical co-operatives.

8.3.1   Company Overview

8.3.2   Financial Performance

8.3.3   Recent Developments

8.3.4   Organ Type Portfolio

8.4      HeartWare Inc.

8.4.1   Company Overview

8.4.2   Financial Performance

8.4.3   Recent Developments

8.4.4   Organ Type Portfolio

8.5      ABIOMED Inc.

8.5.1   Company Overview

8.5.2   Financial Performance

8.5.3   Recent Developments

8.5.4   Organ Type Portfolio

8.6      Organovo holdings

8.6.1   Company Overview

8.6.2   Financial Performance

8.6.3   Recent Developments

8.6.4   Organ Type Portfolio

8.7      Zimmer Biomet

8.7.1   Company Overview

8.7.2   Financial Performance

8.7.3   Recent Developments

8.7.4   Organ Type Portfolio

8.8      Baxter international

8.8.1   Company Overview

8.8.2   Financial Performance

8.8.3   Recent Developments

8.8.4   Organ Type Portfolio

8.9         Others

8.9.1   Company Overview

8.9.2   Financial Performance

8.9.3   Recent Developments

8.9.4   Organ Type Portfolio

9               Conclusion & Recommendations

10             Acronyms & Abbreviations